InvestorsHub Logo
icon url

antihama

05/01/20 3:33 PM

#280981 RE: hope4patients #280890

Geez, if Dendreon Provenge dendritic cell vaccine is making ~$365M/yr rev, what's DCVax-L going to do in sales?